Osteoglophonic dwarfism
Osteoglophonic Dwarfism is a rare genetic disorder characterized by dwarfism, craniosynostosis, rhizomelic short stature, and multiple radiolucent bone lesions. The term 'osteoglophonic' is derived from the Greek words 'osteo' meaning bone, 'glyph' meaning carve, and 'phonic' meaning sound, referring to the characteristic appearance of the bones in this condition.
Etiology[edit | edit source]
Osteoglophonic Dwarfism is caused by mutations in the FGFR1 gene, which provides instructions for making a protein that is involved in the development and maintenance of bone and brain tissue. This mutation leads to the production of an abnormally functioning protein, which interferes with normal bone growth and development.
Clinical Features[edit | edit source]
Individuals with Osteoglophonic Dwarfism typically present with dwarfism, craniosynostosis (premature fusion of the skull bones), rhizomelic short stature (shortening of the proximal parts of the limbs), and multiple radiolucent bone lesions. Other features may include hypodontia (missing teeth), delayed speech development, and hypogonadism (underdevelopment of the sex organs).
Diagnosis[edit | edit source]
Diagnosis of Osteoglophonic Dwarfism is typically made based on the clinical features, radiographic findings, and confirmed by genetic testing for mutations in the FGFR1 gene.
Treatment[edit | edit source]
Treatment for Osteoglophonic Dwarfism is symptomatic and supportive. This may include surgical intervention for craniosynostosis, orthopedic management for skeletal abnormalities, and hormone therapy for hypogonadism.
Prognosis[edit | edit source]
The prognosis for individuals with Osteoglophonic Dwarfism varies depending on the severity of the symptoms and the presence of associated complications. With appropriate management, individuals with this condition can lead a normal life.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Osteoglophonic dwarfism is a rare disease.
This dwarfism related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
